DE3780581T3 - Antiviralen Phosphonomethoxyalkylen-Purin- und -Pyrimidin-Derivate. - Google Patents
Antiviralen Phosphonomethoxyalkylen-Purin- und -Pyrimidin-Derivate.Info
- Publication number
- DE3780581T3 DE3780581T3 DE3780581T DE3780581T DE3780581T3 DE 3780581 T3 DE3780581 T3 DE 3780581T3 DE 3780581 T DE3780581 T DE 3780581T DE 3780581 T DE3780581 T DE 3780581T DE 3780581 T3 DE3780581 T3 DE 3780581T3
- Authority
- DE
- Germany
- Prior art keywords
- antiviral
- pyrimidine derivatives
- phosphonomethoxyalkylene
- purine
- phosphonomethoxyalkylene purine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 title 2
- 230000000840 anti-viral effect Effects 0.000 title 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93211286A | 1986-11-18 | 1986-11-18 | |
US11434087A | 1987-11-04 | 1987-11-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
DE3780581D1 DE3780581D1 (de) | 1992-08-27 |
DE3780581T2 DE3780581T2 (de) | 1992-12-17 |
DE3780581T3 true DE3780581T3 (de) | 1997-06-05 |
Family
ID=26812069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3780581T Expired - Lifetime DE3780581T3 (de) | 1986-11-18 | 1987-11-17 | Antiviralen Phosphonomethoxyalkylen-Purin- und -Pyrimidin-Derivate. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0269947B2 (de) |
JP (1) | JP2593895B2 (de) |
KR (1) | KR950009195B1 (de) |
AU (1) | AU613592B2 (de) |
CA (1) | CA1339780C (de) |
DE (1) | DE3780581T3 (de) |
DK (1) | DK170049B1 (de) |
EG (1) | EG19346A (de) |
ES (1) | ES2033774T5 (de) |
GR (2) | GR3005256T3 (de) |
IL (1) | IL84477A (de) |
NZ (1) | NZ222553A (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS264222B1 (en) * | 1986-07-18 | 1989-06-13 | Holy Antonin | N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them |
IL84477A (en) * | 1986-11-18 | 1995-12-08 | Bristol Myers Squibb Co | History of Phosphonomethoxyalkylene Purinopyrimidine and Pharmaceutical Preparations Containing Them |
EP0338168A1 (de) * | 1988-04-19 | 1989-10-25 | Merrell Dow Pharmaceuticals Inc. | Phosphonoalkylpurin-Derivate |
US5266722A (en) * | 1988-11-09 | 1993-11-30 | W. R. Grace & Co.-Conn. | Polyether bis-phosphonic acid compounds |
US5688778A (en) * | 1989-05-15 | 1997-11-18 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nucleoside analogs |
US5302585A (en) * | 1990-04-20 | 1994-04-12 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents |
ATE124050T1 (de) * | 1990-04-20 | 1995-07-15 | Acad Of Science Czech Republic | Chirale 2-(phosphonomethoxy)propyl-guanine als antivirale agentien. |
SK280313B6 (sk) * | 1990-04-24 | 1999-11-08 | �Stav Organick� Chemie A Biochemie Av �R | N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov |
ES2118069T3 (es) * | 1990-09-14 | 1998-09-16 | Acad Of Science Czech Republic | Profarmacos de fosfonatos. |
US5208221A (en) * | 1990-11-29 | 1993-05-04 | Bristol-Myers Squibb Company | Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives |
KR0184530B1 (ko) * | 1991-10-11 | 1999-05-15 | 카렐 마르티넥 | 항비루스 비고리 포스포노메톡시알킬치환, 알켄일 및 알킨일 퓨린 및 피리미딘 유도체 |
US6057305A (en) * | 1992-08-05 | 2000-05-02 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Antiretroviral enantiomeric nucleotide analogs |
US5656745A (en) * | 1993-09-17 | 1997-08-12 | Gilead Sciences, Inc. | Nucleotide analogs |
US5798340A (en) * | 1993-09-17 | 1998-08-25 | Gilead Sciences, Inc. | Nucleotide analogs |
KR100386685B1 (ko) * | 1993-09-17 | 2003-12-31 | 길리애드 사이언시즈, 인코포레이티드 | 뉴클레오타이드동족체류 |
IT1270008B (it) * | 1994-09-23 | 1997-04-16 | Ist Superiore Sanita | Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids |
US5977061A (en) * | 1995-04-21 | 1999-11-02 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | N6 - substituted nucleotide analagues and their use |
US5717095A (en) * | 1995-12-29 | 1998-02-10 | Gilead Sciences, Inc. | Nucleotide analogs |
JP4033494B2 (ja) * | 1996-07-26 | 2008-01-16 | ギリヤド サイエンシーズ, インコーポレイテッド | ヌクレオチドアナログ |
US5922695A (en) | 1996-07-26 | 1999-07-13 | Gilead Sciences, Inc. | Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability |
AU740264C (en) * | 1997-09-11 | 2002-06-06 | Commonwealth Scientific And Industrial Research Organisation | Antiviral agents |
KR100891366B1 (ko) | 2001-06-29 | 2009-04-02 | 인스티튜트 오브 오르가닉 케미스트리 앤드 바이오케미스트리, 어케더미 오브 사이언시스 오브 더 체크 리퍼블릭 | 항 바이러스 활성을 갖는 6-'2-(포스포노메톡시)알콕시 피리미딘 유도체 |
IL161901A0 (en) * | 2001-11-14 | 2005-11-20 | Biocryst Pharmaceuticals Inc A | Nucleosides, preparation thereof and use as inhibiDevice for the reading and the signalling of environmental parameters tors of rna viral polymerases |
US7388002B2 (en) | 2001-11-14 | 2008-06-17 | Biocryst Pharmaceuticals, Inc. | Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
CN105596356A (zh) | 2003-01-14 | 2016-05-25 | 吉里德科学公司 | 用于联合抗病毒治疗的组合物和方法 |
US7371852B2 (en) | 2003-01-22 | 2008-05-13 | Serenex, Inc. | Alkyl-linked nucleotide compositions |
DK1644389T3 (da) | 2003-06-16 | 2011-05-09 | Acad Of Science Czech Republic | Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger |
US7579332B2 (en) | 2003-07-30 | 2009-08-25 | Gilead Sciences, Inc. | Nucleobase phosphonate analogs for antiviral treatment |
WO2005090370A1 (en) | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
TWI444384B (zh) | 2008-02-20 | 2014-07-11 | Gilead Sciences Inc | 核苷酸類似物及其在治療惡性腫瘤上的用途 |
FI2648701T3 (fi) | 2010-12-10 | 2023-06-12 | Sigmapharm Laboratories Llc | Hyvin stabiileja adefovirdipivoksiilin koostumuksia |
DK2794624T3 (da) | 2011-12-22 | 2019-07-22 | Geron Corp | Guanin-analoger som telomerase-substrater og påvirkere af telomer-længde |
CN103665043B (zh) | 2012-08-30 | 2017-11-10 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药及其在医药上的应用 |
EA036391B1 (ru) * | 2014-09-15 | 2020-11-05 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния | Нуклеотидные аналоги |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS233665B1 (en) | 1983-01-06 | 1985-03-14 | Antonin Holy | Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene |
CS263952B1 (en) * | 1985-04-25 | 1989-05-12 | Holy Antonin | Remedy with antiviral effect |
CS263951B1 (en) * | 1985-04-25 | 1989-05-12 | Antonin Holy | 9-(phosponylmethoxyalkyl)adenines and method of their preparation |
CS264222B1 (en) * | 1986-07-18 | 1989-06-13 | Holy Antonin | N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them |
IL84477A (en) * | 1986-11-18 | 1995-12-08 | Bristol Myers Squibb Co | History of Phosphonomethoxyalkylene Purinopyrimidine and Pharmaceutical Preparations Containing Them |
-
1987
- 1987-11-16 IL IL8447787A patent/IL84477A/en not_active IP Right Cessation
- 1987-11-16 NZ NZ222553A patent/NZ222553A/en unknown
- 1987-11-16 AU AU81250/87A patent/AU613592B2/en not_active Expired
- 1987-11-17 DE DE3780581T patent/DE3780581T3/de not_active Expired - Lifetime
- 1987-11-17 JP JP62290469A patent/JP2593895B2/ja not_active Expired - Lifetime
- 1987-11-17 EG EG65887A patent/EG19346A/xx active
- 1987-11-17 CA CA000551979A patent/CA1339780C/en not_active Expired - Lifetime
- 1987-11-17 EP EP87116996A patent/EP0269947B2/de not_active Expired - Lifetime
- 1987-11-17 DK DK604087A patent/DK170049B1/da not_active IP Right Cessation
- 1987-11-17 ES ES87116996T patent/ES2033774T5/es not_active Expired - Lifetime
- 1987-11-18 KR KR1019870012967A patent/KR950009195B1/ko not_active IP Right Cessation
-
1992
- 1992-07-23 GR GR920401473T patent/GR3005256T3/el unknown
-
1996
- 1996-10-17 GR GR960400474T patent/GR3021389T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2593895B2 (ja) | 1997-03-26 |
ES2033774T3 (es) | 1993-04-01 |
JPS63170388A (ja) | 1988-07-14 |
DK170049B1 (da) | 1995-05-08 |
GR3021389T3 (en) | 1997-01-31 |
DK604087D0 (da) | 1987-11-17 |
KR880006256A (ko) | 1988-07-22 |
KR950009195B1 (ko) | 1995-08-16 |
EP0269947B1 (de) | 1992-07-22 |
CA1339780C (en) | 1998-03-24 |
ES2033774T5 (es) | 1997-03-16 |
DE3780581D1 (de) | 1992-08-27 |
IL84477A (en) | 1995-12-08 |
GR3005256T3 (en) | 1993-05-24 |
AU613592B2 (en) | 1991-08-08 |
AU8125087A (en) | 1988-05-19 |
EG19346A (en) | 1995-01-31 |
EP0269947B2 (de) | 1996-10-16 |
DE3780581T2 (de) | 1992-12-17 |
EP0269947A1 (de) | 1988-06-08 |
DK604087A (da) | 1988-05-19 |
NZ222553A (en) | 1991-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3780581D1 (de) | Antiviralen phosphonomethoxyalkylen-purin- und -pyrimidin-derivate. | |
DE3650130T2 (de) | Antivirale Nukleoside. | |
DK366887A (da) | Pyrimidinderivater | |
NL960006I2 (nl) | Purine-derivaten en de farmaceutische toepassing daarvan. | |
DK640388A (da) | Pyrimidinderivater | |
DK247889D0 (da) | Pyrimidinderivater | |
DE3788385D1 (de) | Pyrimidin-Derivate. | |
DK375787A (da) | Pyrimidinderivater | |
DK158589A (da) | Pyrimidinderivater | |
FI893948A (fi) | Antiviral behandlingsfoerfarande. | |
OA08120A (fr) | Purine derivatives. | |
DK122587A (da) | Pyrazolo(3,4-d)pyrimidinderivater og fremstilling og anvendelse deraf | |
IT8422739A0 (it) | Derivati nucleosidici e purinici 8-sostituiti. | |
NO884830D0 (no) | Purin-derivater. | |
MC1844A1 (fr) | Derives de pyrimidine | |
DK227388A (da) | Pyrimidinderivater | |
DK71187A (da) | Purinderivater | |
DE3884347T2 (de) | Pyrimidinderivate. | |
MC1845A1 (fr) | Derives de pyrimidine | |
BG82461A (bg) | Пиримидинови производни | |
DE3780343T2 (de) | Antivirale 8-phenylxanthine. | |
ATE78485T1 (de) | Antiviralen phosphonomethoxyalkylen-purin- und - pyrimidin-derivate. | |
ATA282287A (de) | Antivirale 8-phenylxanthine | |
IT8821190A0 (it) | Derivati purinici aventi attivita' antivirale. | |
ZA878607B (en) | Antiviral phosphonomethyoxyalkylene purine and pyrmadine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8328 | Change in the person/name/address of the agent |
Free format text: BARZ, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 80803 MUENCHEN |
|
8366 | Restricted maintained after opposition proceedings |